Respiratory Syncytial Virus (RSV)

RSV is a highly contagious virus that affects the lungs and airways, spreading through coughing, sneezing, and touching contaminated surfaces. While most cases cause mild cold-like symptoms, RSV can lead to serious complications in infants, older adults, and people with weakened immune systems.

• Symptoms
  • Runny nose, cough, sneezing, and fever
  • Wheezing and difficulty breathing
  • Poor feeding and irritability in infants
• Symptoms appear 2-8 days after exposure and last 1-2 weeks
• Serious Risks for Infants and High-Risk Individuals
  • RSV is the #1 cause of bronchiolitis and pneumonia in infants under 1 year old.
  • Premature babies, infants under 6 months, and those with heart/lung conditions are at the highest risk.
  • 1-2% of infected infants require hospitalization for oxygen, fluids, and breathing support.
  • In older adults, RSV can cause severe pneumonia and worsen existing conditions like asthma or heart disease.
• Prevention & Treatment
  • There is no specific cure for RSV—only supportive care like fluids, oxygen, and fever reducers.
  • Preventive monoclonal antibody treatments are available for infants under 8 months of age.
  • An RSV vaccine is available for pregnant women and older adults to help protect newborns and vulnerable individuals.
  • While RSV is common, it can be life-threatening for infants and high-risk individuals. Taking preventive measures and recognizing early symptoms can help ensure prompt care and protection.

 

The RSV Antibody remains the best protection against RSV. Stay protected. Stay informed.

Here are videos that go into more detail about RSV.